Exporter Supply Landscape

Supplier countries for containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale

A reported trade view for HS 300439, with available observations through 2024.

HS6 300439Coverage 1995-2024Updated 2026-08-14
Explore this product

Leading supplier

Italy$9.9B

Supplier countries

197Reported suppliers

Top supplier reach

133Destination markets

Latest global trade

$44.3BYear: 2024

Reported observations

Supplier evidence

Supplier countries ranked by latest reported export value.

SupplierLatest exports5-year growthDestinationsLeading destination
Italy$9.9B+25.1%133USA
Denmark$6.6B+2.4%97China
Germany$4.8B+10.5%138USA
France$3.6B-0.7%147USA
USA$2.9B+21.4%128Japan
Austria$2.7B+1.3%87Switzerland, Liechtenstein
Switzerland, Liechtenstein$2.6B+1.1%120USA
Ireland$1.8B+8.6%98USA
Belgium$1.7B-7.6%150Italy
China$1.4B+104.2%135Denmark
United Kingdom$1.2B-0.2%140China
Canada$830.3M-0.4%95USA
Netherlands$790.0M-8.9%164China
Spain$632.0M+8.4%117USA
Japan$369.6M+0.3%55USA
India$265.4M+8.6%179USA
Hungary$261.0M+3.5%77Germany
Brazil$191.8M-2.2%87Denmark
Czechia$191.1M-4%86Germany
Sweden$142.9M-0.6%67USA
Poland$134.6M+8.6%90Republic of Korea
Portugal$129.9M+30%63USA
Argentina$113.4M+9.9%56Brazil
Greece$108.8M+27.9%64USA
Republic of Korea$107.7M+3.9%63Brazil
Slovenia$95.2M+12.5%63Kazakhstan
Mexico$84.2M+9.9%41Colombia
Pakistan$81.3M+24.1%54Afghanistan
Croatia$81.0M+26.7%38USA
Singapore$67.9M-29.8%51USA
Romania$53.4M+7.1%45Germany
Bulgaria$52.9M+14.6%50Russia
United Arab Emirates$51.4M+4%89Iran
Slovakia$48.0M-6%34Czechia
Latvia$47.7M+16.1%64Lithuania

Market reading

Which countries supply containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale?

Italy is the leading reported supplier in this view, with exports of $9.9B.

How to use this view

Start with the leading rows in the first table, then use the chart to compare supplier scale and destination reach for containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale. The second table adds a related reported comparison.

Coverage extends to 2024. Missing values are shown as not reported.

Further comparison

Supplier corridor unit-value evidence

Reported corridor unit values for the selected supplier, compared with each buyer market's median.

Buyer marketReported yearTrade valueQuantityUnit value USD/tonBuyer-market median USD/ton
USA2023$1.6B989 t$1,639,045.71$512,125.66
Belgium2023$934.3M284.9 t$3,279,107.43$232,000
France2023$597.8M1,385.7 t$431,391.16$292,370.37
Germany2023$520.4M1,308.8 t$397,605$291,214.91
Switzerland, Liechtenstein2023$174.6M144.9 t$1,204,896.87$396,500
United Kingdom2023$135.9M325.6 t$417,515.5$188,943.99
Spain2023$69.4M238.6 t$290,995.52$218,185.07
Israel2023$56.6M1,028.8 t$55,024.64$285,464.29
China2023$39.6M176.6 t$224,291.63$646,545.25
Japan2023$35.8M11.3 t$3,151,015.25$794,982.14
Canada2023$27.3M100.1 t$272,380.87$428,556.44
India2023$24.8M86.2 t$288,071.26$237,500
Turkey2023$15.8M93.3 t$168,800.78$260,682.73
Brazil2023$15.3M156.4 t$97,752.95$502,785.61
Czechia2023$15.1M46.2 t$328,193.26$395,786.24
Greece2023$14.4M67.4 t$214,140.54$305,766.63
United Arab Emirates2023$14.3M432.8 t$32,982.97$154,189.87
Poland2023$13.9M85.4 t$162,958.09$274,874.03
Sweden2023$13.6M33.9 t$399,549.04$386,666.67
Argentina2023$12.8M19.8 t$645,765.6$281,650.32

Explore related views

Continue with another perspective on this product.

Latest observed year: 2024. Page updated 2026-08-14.

Source and date

Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.

Definitions

Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.

Reading the data

“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.